Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial

Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet infectious diseases 2021-05, Vol.21 (5), p.688
Hauptverfasser: Davis, Kimberly, Valente Pinto, Marta, Andrews, Nick J, Goldblatt, David, Borrow, Ray, Findlow, Helen, Southern, Jo, Partington, Jo, Plested, Emma, Patel, Sima, Holland, Ann, Matheson, Mary, England, Anna, Hallis, Bassam, Miller, Elizabeth, Snape, Matthew D
Format: Artikel
Sprache:eng
Schlagworte:
Analysis
Meningitis
Vaccines
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page 688
container_title The Lancet infectious diseases
container_volume 21
creator Davis, Kimberly
Valente Pinto, Marta
Andrews, Nick J
Goldblatt, David
Borrow, Ray
Findlow, Helen
Southern, Jo
Partington, Jo
Plested, Emma
Patel, Sima
Holland, Ann
Matheson, Mary
England, Anna
Hallis, Bassam
Miller, Elizabeth
Snape, Matthew D
description
doi_str_mv 10.1016/S1473-3099(20)30600-9
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_incontextgauss__A659406282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A659406282</galeid><sourcerecordid>A659406282</sourcerecordid><originalsourceid>FETCH-gale_incontextgauss__A6594062823</originalsourceid><addsrcrecordid>eNqNi01LBDEQRHNQcP34CUKfRGFHOzPjrONNRVE8quchZntjpJNeJoko_nlnQTx7qqLeK6UONZ5q1N3Zk24XTdVg3x_XeNJgh1j1W2r2N--o3ZTeEfVCYztT3w8hlCiOorc-f4GsIL8RvDyCG6Ws4RrChKITK9Yahg9jrY8ElyAlWwmUNhcDoXD2lmIeaQ6yplixeSWew2jiUoJPtAQrExbmqebRG95X2yvDiQ5-c08d3d0-39xXzjANPm58-szOlJSG4ao771vs6ou6-bf4A6JAViU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial</title><source>Elsevier ScienceDirect Journals</source><creator>Davis, Kimberly ; Valente Pinto, Marta ; Andrews, Nick J ; Goldblatt, David ; Borrow, Ray ; Findlow, Helen ; Southern, Jo ; Partington, Jo ; Plested, Emma ; Patel, Sima ; Holland, Ann ; Matheson, Mary ; England, Anna ; Hallis, Bassam ; Miller, Elizabeth ; Snape, Matthew D</creator><creatorcontrib>Davis, Kimberly ; Valente Pinto, Marta ; Andrews, Nick J ; Goldblatt, David ; Borrow, Ray ; Findlow, Helen ; Southern, Jo ; Partington, Jo ; Plested, Emma ; Patel, Sima ; Holland, Ann ; Matheson, Mary ; England, Anna ; Hallis, Bassam ; Miller, Elizabeth ; Snape, Matthew D</creatorcontrib><identifier>ISSN: 1473-3099</identifier><identifier>DOI: 10.1016/S1473-3099(20)30600-9</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Analysis ; Meningitis ; Vaccines</subject><ispartof>The Lancet infectious diseases, 2021-05, Vol.21 (5), p.688</ispartof><rights>COPYRIGHT 2021 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Davis, Kimberly</creatorcontrib><creatorcontrib>Valente Pinto, Marta</creatorcontrib><creatorcontrib>Andrews, Nick J</creatorcontrib><creatorcontrib>Goldblatt, David</creatorcontrib><creatorcontrib>Borrow, Ray</creatorcontrib><creatorcontrib>Findlow, Helen</creatorcontrib><creatorcontrib>Southern, Jo</creatorcontrib><creatorcontrib>Partington, Jo</creatorcontrib><creatorcontrib>Plested, Emma</creatorcontrib><creatorcontrib>Patel, Sima</creatorcontrib><creatorcontrib>Holland, Ann</creatorcontrib><creatorcontrib>Matheson, Mary</creatorcontrib><creatorcontrib>England, Anna</creatorcontrib><creatorcontrib>Hallis, Bassam</creatorcontrib><creatorcontrib>Miller, Elizabeth</creatorcontrib><creatorcontrib>Snape, Matthew D</creatorcontrib><title>Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial</title><title>The Lancet infectious diseases</title><subject>Analysis</subject><subject>Meningitis</subject><subject>Vaccines</subject><issn>1473-3099</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqNi01LBDEQRHNQcP34CUKfRGFHOzPjrONNRVE8quchZntjpJNeJoko_nlnQTx7qqLeK6UONZ5q1N3Zk24XTdVg3x_XeNJgh1j1W2r2N--o3ZTeEfVCYztT3w8hlCiOorc-f4GsIL8RvDyCG6Ws4RrChKITK9Yahg9jrY8ElyAlWwmUNhcDoXD2lmIeaQ6yplixeSWew2jiUoJPtAQrExbmqebRG95X2yvDiQ5-c08d3d0-39xXzjANPm58-szOlJSG4ao771vs6ou6-bf4A6JAViU</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Davis, Kimberly</creator><creator>Valente Pinto, Marta</creator><creator>Andrews, Nick J</creator><creator>Goldblatt, David</creator><creator>Borrow, Ray</creator><creator>Findlow, Helen</creator><creator>Southern, Jo</creator><creator>Partington, Jo</creator><creator>Plested, Emma</creator><creator>Patel, Sima</creator><creator>Holland, Ann</creator><creator>Matheson, Mary</creator><creator>England, Anna</creator><creator>Hallis, Bassam</creator><creator>Miller, Elizabeth</creator><creator>Snape, Matthew D</creator><general>Elsevier B.V</general><scope/></search><sort><creationdate>20210501</creationdate><title>Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial</title><author>Davis, Kimberly ; Valente Pinto, Marta ; Andrews, Nick J ; Goldblatt, David ; Borrow, Ray ; Findlow, Helen ; Southern, Jo ; Partington, Jo ; Plested, Emma ; Patel, Sima ; Holland, Ann ; Matheson, Mary ; England, Anna ; Hallis, Bassam ; Miller, Elizabeth ; Snape, Matthew D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_incontextgauss__A6594062823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Meningitis</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davis, Kimberly</creatorcontrib><creatorcontrib>Valente Pinto, Marta</creatorcontrib><creatorcontrib>Andrews, Nick J</creatorcontrib><creatorcontrib>Goldblatt, David</creatorcontrib><creatorcontrib>Borrow, Ray</creatorcontrib><creatorcontrib>Findlow, Helen</creatorcontrib><creatorcontrib>Southern, Jo</creatorcontrib><creatorcontrib>Partington, Jo</creatorcontrib><creatorcontrib>Plested, Emma</creatorcontrib><creatorcontrib>Patel, Sima</creatorcontrib><creatorcontrib>Holland, Ann</creatorcontrib><creatorcontrib>Matheson, Mary</creatorcontrib><creatorcontrib>England, Anna</creatorcontrib><creatorcontrib>Hallis, Bassam</creatorcontrib><creatorcontrib>Miller, Elizabeth</creatorcontrib><creatorcontrib>Snape, Matthew D</creatorcontrib><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davis, Kimberly</au><au>Valente Pinto, Marta</au><au>Andrews, Nick J</au><au>Goldblatt, David</au><au>Borrow, Ray</au><au>Findlow, Helen</au><au>Southern, Jo</au><au>Partington, Jo</au><au>Plested, Emma</au><au>Patel, Sima</au><au>Holland, Ann</au><au>Matheson, Mary</au><au>England, Anna</au><au>Hallis, Bassam</au><au>Miller, Elizabeth</au><au>Snape, Matthew D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial</atitle><jtitle>The Lancet infectious diseases</jtitle><date>2021-05-01</date><risdate>2021</risdate><volume>21</volume><issue>5</issue><spage>688</spage><pages>688-</pages><issn>1473-3099</issn><pub>Elsevier B.V</pub><doi>10.1016/S1473-3099(20)30600-9</doi><tpages>688</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2021-05, Vol.21 (5), p.688
issn 1473-3099
language eng
recordid cdi_gale_incontextgauss__A659406282
source Elsevier ScienceDirect Journals
subjects Analysis
Meningitis
Vaccines
title Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunogenicity%20of%20the%20UK%20group%20B%20meningococcal%20vaccine%20:%20outcomes%20of%20a%20multicentre,%20open-label,%20randomised%20controlled%20trial&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Davis,%20Kimberly&rft.date=2021-05-01&rft.volume=21&rft.issue=5&rft.spage=688&rft.pages=688-&rft.issn=1473-3099&rft_id=info:doi/10.1016/S1473-3099(20)30600-9&rft_dat=%3Cgale%3EA659406282%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A659406282&rfr_iscdi=true